Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Constellation Pharmaceuticals revenue
Constellation Pharmaceuticals's revenue is $4.7 million.
What is Constellation Pharmaceuticals's revenue?
- Constellation Pharmaceuticals has 82 employees, and the revenue per employee ratio is $57,317.
- Constellation Pharmaceuticals peak revenue was $4.7M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Constellation Pharmaceuticals financial information
| CEO | Jigar Raythatha |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 82 |
| Date Founded | 2008 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 1 |
| Revenue | $4.7M |
| Net Income | -$126,357,000 |
| Tax Rate | -0.0% |
| Total Assets | $441,854,000 |
| Ticker | CNST |
Constellation Pharmaceuticals jobs you might like
Constellation Pharmaceuticals financing
Constellation Pharmaceuticals received early financing of $32.0M on 2008-04-29.
| Series | Round size | Date |
|---|---|---|
| Series A | $32M | 04/2008 |
| Series A | $17.2M | 08/2009 |
| Series B | $22.3M | 06/2010 |
| Series B | $15M | 06/2011 |
| Series C | $95M | 01/2012 |
| Series D | $5M | 08/2014 |
| Series E | $55M | 12/2015 |
| Series E | $48.5M | 07/2017 |
| Grant | $1.3M | 12/2017 |
| Series F | $100M | 04/2018 |
| Post Ipo Debt | $40M | 03/2019 |
| Post Ipo Equity | $65M | 10/2019 |
Constellation Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Venrock | Series A |
| Third Rock Ventures | Series A |
| The Column Group | Series A |
| Altitude Life Science Ventures | Series A |
| Venrock | Series A |
| Third Rock Ventures | Series A |
| The Column Group | Series A |
| SR One | Series B |
| Altitude Life Science Ventures | Series B |
| Venrock | Series B |
| Third Rock Ventures | Series B |
| The Column Group | Series B |
| SR One | Series B |
| Altitude Life Science Ventures | Series B |
| Venrock | Series B |
| Third Rock Ventures | Series B |
| The Column Group | Series B |
| Genentech | Series C |
| Topspin Partners | Series E |
| Solon Mack Capital | Series E |
| Venrock | Series E |
| Third Rock Ventures | Series E |
| The Column Group | Series E |
| Topspin Partners | Series E |
| University of California Investment Office | Series E |
| Venrock | Series E |
| Third Rock Ventures | Series E |
| The Column Group | Series E |
| Massachusetts Clean Energy Center | Grant |
| Topspin Partners | Series F |
| SR One | Series F |
| Venrock | Series F |
| Deerfield | Series F |
| NS Investment | Series F |
| Hillhouse Capital Group | Series F |
| Fidelity Management & Research Co LLC | Series F |
| The Column Group | Series F |
| Sirona Capital | Series F |
| Solon Mack Capital | Series F |
| University of California Investment Office | Series F |
| Cormorant Asset Management | Series F |
| Third Rock Ventures | Series F |
| OrbiMed Advisors | Series F |
| Casdin Capital | Series F |
| HERCULES CAPITAL INC | Post Ipo Debt |
| Bain Capital Life Sciences | Post Ipo Equity |
| Venrock Healthcare Capital Partners | Post Ipo Equity |
| The Column Group | Post Ipo Equity |
Constellation Pharmaceuticals competitors
Constellation Pharmaceuticals's top competitor, Agios Pharmaceuticals, earned an annual revenue of $94.4M.
Constellation Pharmaceuticals's smallest competitor is Pinnacle Pharmaceuticals with revenue of $370.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Momenta Pharmaceuticals | - | $30.1M | 131 | - |
| Agios Pharmaceuticals | - | $94.4M | 536 | - |
| Celtaxsys | - | $11.4M | 30 | - |
| CNS Online | - | $5.0M | 3 | - |
| Tetraphase Pharmaceuticals | - | $7.4M | 67 | - |
| Pinnacle Pharmaceuticals | - | $370,000 | 2 | - |
Constellation Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Constellation Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Constellation Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Constellation Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Constellation Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Constellation Pharmaceuticals. The data presented on this page does not represent the view of Constellation Pharmaceuticals and its employees or that of Zippia.
Constellation Pharmaceuticals may also be known as or be related to CONSTELLATION PHARMACEUTICALS INC, Constellation Pharmaceuticals, Constellation Pharmaceuticals Inc and Constellation Pharmaceuticals, Inc.